Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Inc reported a 20% jump in second-quarter revenue on Monday, as the Canadian pot producer benefited from higher demand for cannabis and related products.

Tilray reports 20% jump in revenue on higher demand

New Parent Company Name, TILRAY BRANDS, Reflects Growing Portfolio of Leading, Global CPG Brands New Parent Company Name, TILRAY BRANDS, Reflects Growing Portfolio of Leading, Global CPG Brands

Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

SNDL Inc.

Canopy Growth

There's big money in marijuana -- for the governments that legalize it.

Why Canopy, Sundial, and Tilray Stocks Just Popped

Canadian cannabis giant Tilray Inc. (NASDAQ:TLRY) is scheduled to report its financial results for the second quarter of fiscal 2022 on Monday, Jan. 10, as its stock continues to sink ahead of the event. It was last seen down 1.71% at $6.51.

Will Tilray Stock Continue To Drop? Analyst's Thoughts Ahead Of Q2 Earnings Report

Tilray Inc. will likely grow its sales over the previous quarter but it's expected to post a net loss when it becomes the first major cannabis company to post quarterly results in 2022 on Monday.

Cannabis Watch: Tilray expected to grow sales sequentially but remain in the red

Marijuana producer Tilray Inc (NASDAQ:TLRY) is gearing up for its fiscal second-quarter earnings report, which is due out before the open on Monday, Jan. 10.

Tilray Stock Hits Annual Lows Ahead of Earnings Report

Albertsons Companies

Commercial Metals

The first results are in for quarterly earnings reports out in January. Of the companies we previewed earlier this week, Bed Bath & Beyond, Conagra Brands and Schnitzer Steel all missed profit estimates, and the first two also missed on revenues as well.

Earnings Previews: Albertsons, Commercial Metals, Tilray

Tilray Inc. (NASDAQ:TLRY) shares are trading lower Wednesday as the cannabis sector declines as a whole. The stock has recently fallen below support in what traders call a sideways channel and appears to be dropping further from the support level.

Tilray Continues To Slide Lower, Is A Bounce To Higher Prices In Sight?

Among the 20 most searched tickers on Benzinga in 2021 were two well-known cannabis companies. Here are their names and why they were heavily searched in 2021.

These 2 Cannabis Stocks Were Among The Most Searched Benzinga Tickers In 2021: Here's Why

TLRY stock is likely to keep falling if the company can't start producing positive profits or positive free cash flow. The post Tilray Falls Along With Its Burning Free Cash Flow appeared first on InvestorPlace.

Tilray Falls Along With Its Burning Free Cash Flow

Investors lost interest in the marijuana space in late 2021.

Why Tilray Stock Fell 31% in December

Despite some positives, TLRY stock still has plenty to do before it can come close to achieving its $4 billion revenue target by 2024. The post Tilray Isn't Your Cannabis Bet for the Long-Haul appeared first on InvestorPlace.

Tilray Isn't Your Cannabis Bet for the Long-Haul

Cronos Group

Best Canadian Pot Stocks For January 2022 The post Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks For Your January 2022 Watchlist Right Now

TLRY stock is cheap now but just because it's skidding doesn't mean investors will rush in and send prices higher. The post Tilray Stock May Have Nowhere Else to Go but up From These Levels appeared first on InvestorPlace.

Tilray Stock May Have Nowhere Else to Go but up From These Levels

TLRY stock looks attractive after correction. The market is getting bigger and Tilray has presence in medicinal and recreational cannabis.

Tilray Stock Is Oversold Here and on the Verge of a Turnaround Rally

With the acquisition of Breckenridge Distillery, Tilray is undergoing a horizontal expansion to increase its offering in the beverage alcohol sector.

Tilray; capturing the cannabis market with another acquisition

2 Marijuana Stocks To Watch At The Start Of 2022 The post Marijuana Stocks To Watch After January 1st appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Marijuana Stocks To Watch After January 1st

Hive Blockchain Technologies Ltd

Lucid Group

Marathon Digital Holdings

Roblox

Growth stocks that can be accumulated in the recent correction. Growth stocks that can potentially double in 2022.

7 of the Best Growth Stocks to Buy for 2022

Aurora Cannabis

This article by Johnny Green was originally published on Cannabis & Tech Today, and appears here with permission. The cost of cannabis flower has fluctuated throughout the years.

Cheap Weed: How Low Will Cannabis Prices Go In The Future?

Green Thumb Industries Inc.

A new year brings new laws expanding marijuana availability.

Why Marijuana Stocks Glowed Green Today

Bakkt Holdings

Cleveland-Cliffs

Nokia

Pubmatic

Cassava Sciences Inc

Virgin Galactic

Although the meme stocks phenomenon is sagging in popularity, these seven current and/or former Reddit favorites could make another "to the moon" move or two in 2022. The post 7 of the Best Meme Stocks for 2022 to Buy Now appeared first on InvestorPlace.

7 of the Best Meme Stocks for 2022 to Buy Now

BAD ETF

InMed Pharmaceuticals

Neptune Wellness Solutions Inc.

OrganiGram Holdings Inc.

The Valens Co

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up as we round out 2021.

8 Cannabis Stocks Ablaze During Christmas Week

Tilray, Inc. (TLRY) closed at $7.84 in the latest trading session, marking a +1.29% move from the prior day.

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

Innovative Industrial Properties

Block

Legalization at state level is ramping up and once federal legalization is achieved marijuana stocks like Tilray, Inc. (TLRY), Sundial Growers (SNDL), Block Inc. (SQ) and Innovative Industrial Properties, Inc. (IIPR) are poised to perform well.

4 Marijuana Stocks to Watch as Legalization Efforts Intensify

TLRY stock holders should finally catch a break in the near future as Tilray finalizes a value-added cannabis beverages acquisition. The post Tilray Got Smoked, but Investors Should See Green Soon appeared first on InvestorPlace.

Tilray Got Smoked, but Investors Should See Green Soon

News for Tilray Brands Stock (TLRY)